These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25578549)

  • 1. [Blood transfusion: the challenges for tomorrow?].
    Folléa G; Garraud O; Tiberghien P
    Presse Med; 2015 Feb; 44(2):227-32. PubMed ID: 25578549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking blood components and patients: Patient blood management. Possible ways for development in France.
    Folléa G
    Presse Med; 2016; 45(7-8 Pt 2):e273-80. PubMed ID: 27476011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [European Blood Alliance (EBA) and EuroNet TMS: what challenges for the transfusion of tomorrow?].
    Folléa G; de Wit J; Rouger P
    Transfus Clin Biol; 2011 Apr; 18(2):106-14. PubMed ID: 21458349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.
    Potocnik M
    Transfus Clin Biol; 2005 Feb; 12(1):21-4. PubMed ID: 15814288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is haemovigilance improving transfusion practice?--The european experience.
    Strengers PF
    Dev Biol (Basel); 2007; 127():215-24. PubMed ID: 17486895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Why is it necessary to review the December 15th 2003 circular relative to the transfusion act?].
    Lassale B; Besse-Moreau M; Aullen JP
    Transfus Clin Biol; 2014 Nov; 21(4-5):223-6. PubMed ID: 25267206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability.
    Bates I; Manyasi G; Medina Lara A
    Transfus Med; 2007 Dec; 17(6):434-42. PubMed ID: 18067647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion medicine in the 2000s, on a reform].
    Hervé P
    Bull Acad Natl Med; 2002; 186(2):379-89; discussion 389-92. PubMed ID: 12145845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [French haemovigilance from 1994 to nowadays: Evolution and prospects].
    Lassale B; Daurat G; Besse-Moreau M; Aullen JP
    Transfus Clin Biol; 2017 Sep; 24(3):268-272. PubMed ID: 28647104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The transfusion chain: from donor to recipient].
    Beauplet A
    Rev Prat; 2001 Jun; 51(12):1294-8. PubMed ID: 11503501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality assurance in blood transfusion].
    Chevrolle F
    Ann Pharm Fr; 2002 Sep; 60(5):318-25. PubMed ID: 12378141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The safety of blood donors].
    Courchelle J; Baudry C; Bourboul MC; Coudurier N
    Transfus Clin Biol; 2011 Apr; 18(2):189-92. PubMed ID: 21440480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for improving quality in the transfusion service.
    Berte LM
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S36-42. PubMed ID: 9124228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products.
    Wright C; Velickovic Z; Brown R; Larsen S; Macpherson JL; Gibson J; Rasko JE
    Pathology; 2014 Apr; 46(3):177-83. PubMed ID: 24614714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality indicators and dashboards: the experience of a collection department].
    Danic B; Bécel C; Beauplet A
    Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide overview of existing haemovigilance systems.
    Faber JC
    Transfus Apher Sci; 2004 Oct; 31(2):99-110. PubMed ID: 15501414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.